Speaker: Chitra Edwin - Consultant,Biotechnology
Consulting Solutions
Date: December 8th
Thursday
Time: 01:00 PM EST
| 10:00 AM PST
Duration: 60
Minutes
Product Code: 300193
Level: Intermediate
Key Take Away
This webinar
will provide a clear understanding of the basics of GLP and cGMP compliance in
drug development (non-clinical testing, and manufacturing of drugs).
Overview
Get a comprehensive overview of the key compliance
regulations required for GLP laboratory compliance for non-clinical testing in drug development. And, also a
comprehensive overview of the cGMP
regulations for the manufacturing in pharmaceutical development.
Why Should You Attend
No FUDs are expected. Compliance
based on the regulations are well established, and documented in key guidance
documents. Any personnel working in these areas must adhere to the regulations.
It is “black and white”, and straightforward.
Areas Covered In This Webinar
·
Historical background
·
Applicable guidance’s and regulations
·
Case Studies
Learning Objectives
·
Requirements at each level; testing laboratory,
manufacturing facility, animal facility, CRMs, key reagents, labeling, SOPs,
documentation
·
Preparing for audits
·
Penalties for non-c
·
Scientists
·
Analysts
·
Technicians
·
Supervisors
·
Laboratory Directors
Who Will Benefit
·
Scientists
·
Analysts
·
Technicians
·
Supervisors
·
Laboratory Directors
Speakers Profile
Chitra
Edwin, Ph.D., RAC. has extensive experience in the
product development, regulatory affairs, strategy and compliance of in vitro
diagnostics (IVD), medical devices and biologics (vaccines) in infectious
diseases, oncology, and cardiology. She has held leadership roles in the
private sector including the Cleveland HeartLab, MassBiologics, and Chiron
Diagnostics. Dr. Edwin is an Adjunct Associate Professor of Pharmaceutical
Sciences, College of Pharmacy, University of Cincinnati.
Dr. Edwin obtained her Ph.D. in from the University of
Minnesota, and post-doctoral training at the Harvard Medical School and the
Dana Farber Cancer Institute. She is Regulatory Affairs Certified (RAC). She was
a Review Board member of Opus Institutional Review Board (IRB).
No comments:
Post a Comment